Sarin PS - Search Results

1

CD4-modified synthetic peptides containing phenylalanine inhibit HIV-1 infection in vitro.

Lasarte JJ, Sarobe P, Golvano J, Prieto I, Civeira MP, Gullón A, Sarin PS, Prieto J, Borrás-Cuesta F. Lasarte JJ, et al. Among authors: sarin ps. J Acquir Immune Defic Syndr (1988). 1994 Feb;7(2):129-34. J Acquir Immune Defic Syndr (1988). 1994. PMID: 8301524

2

Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides.

Goodchild J, Agrawal S, Civeira MP, Sarin PS, Sun D, Zamecnik PC. Goodchild J, et al. Among authors: sarin ps. Proc Natl Acad Sci U S A. 1988 Aug;85(15):5507-11. doi: 10.1073/pnas.85.15.5507. Proc Natl Acad Sci U S A. 1988. PMID: 3041414 Free PMC article.

3

Inhibition of acquired immunodeficiency syndrome virus by oligodeoxynucleoside methylphosphonates.

Sarin PS, Agrawal S, Civeira MP, Goodchild J, Ikeuchi T, Zamecnik PC. Sarin PS, et al. Proc Natl Acad Sci U S A. 1988 Oct;85(20):7448-51. doi: 10.1073/pnas.85.20.7448. Proc Natl Acad Sci U S A. 1988. PMID: 3174646 Free PMC article.

4

Specific antibody responses to synthetic peptides of HIV-1 p17 correlate with different stages of HIV-1 infection.

Jiang JD, Chu FN, Naylor PH, Kirkley JE, Mandeli J, Wallace JI, Sarin PS, Goldstein AL, Holland JF, Bekesi JG. Jiang JD, et al. Among authors: sarin ps. J Acquir Immune Defic Syndr (1988). 1992;5(4):382-90. J Acquir Immune Defic Syndr (1988). 1992. PMID: 1372353

5

Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus.

Agrawal S, Goodchild J, Civeira MP, Thornton AH, Sarin PS, Zamecnik PC. Agrawal S, et al. Among authors: sarin ps. Proc Natl Acad Sci U S A. 1988 Oct;85(19):7079-83. doi: 10.1073/pnas.85.19.7079. Proc Natl Acad Sci U S A. 1988. PMID: 3174622 Free PMC article.

6

High expression of multinucleated giant cells in cultures of peripheral blood cells from HIV infected patients.

Bigi G, Stone G, Cerri A, Sun D, Sarin PS. Bigi G, et al. Among authors: sarin ps. Haematologica. 1990 May-Jun;75(3):212-9. Haematologica. 1990. PMID: 2227616

7

HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individuals.

Achour A, Picard O, Zagury D, Sarin PS, Gallo RC, Naylor PH, Goldstein AL. Achour A, et al. Among authors: sarin ps. Proc Natl Acad Sci U S A. 1990 Sep;87(18):7045-9. doi: 10.1073/pnas.87.18.7045. Proc Natl Acad Sci U S A. 1990. PMID: 1698289 Free PMC article.

8

Cross-clade p17 peptide recognition by antisera to HGP-30, a 30-amino acid synthetic peptide antigen from HIV type 1 p17.

Zimmerman DH, Ulrich JT, Wright C, Lloyd JP, Winship MD, Sarin PS. Zimmerman DH, et al. Among authors: sarin ps. AIDS Res Hum Retroviruses. 1998 Jun 10;14(9):741-9. doi: 10.1089/aid.1998.14.741. AIDS Res Hum Retroviruses. 1998. PMID: 9643374

9

Immune response and epitope mapping of a candidate HIV-1 p17 vaccine HGP30.

Boucher CA, Krone WJ, Goudsmit J, Meloen RH, Naylor PH, Goldstein AL, Sun DK, Sarin PS. Boucher CA, et al. Among authors: sarin ps. J Clin Lab Anal. 1990;4(1):43-7. doi: 10.1002/jcla.1860040109. J Clin Lab Anal. 1990. PMID: 1690277

10

Cell-mediated immunity against HGP-30, a group-specific peptide of HIV p17 in individuals infected with the AIDS virus.

Willer A, Achour A, Mbika JP, Laaroubi K, Lachgar A, Nihrane A, Picard O, Naylor PH, Sarin PS, Goldstein AL, et al. Willer A, et al. Among authors: sarin ps. Biomed Pharmacother. 1992;46(8):359-65. doi: 10.1016/0753-3322(92)90304-p. Biomed Pharmacother. 1992. PMID: 1292646 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

141 results

Search Page

Filters